24 Participants Needed

Exercise Program for Lymphoma

CD
Overseen ByChristina Dieli-Conwright, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Dana-Farber Cancer Institute
Must be taking: R-CHOP, POLA-R-CHP
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Interrupted Sedentary Time Intervention for lymphoma?

Research shows that being physically active improves survival rates and quality of life for lymphoma patients. Increasing physical activity after diagnosis is linked to better overall survival and lymphoma-specific survival, suggesting that interventions like Interrupted Sedentary Time could be beneficial.12345

Is exercise safe for lymphoma patients?

Exercise programs, including aerobic exercise, appear to be safe for lymphoma patients and can improve fitness and reduce fatigue. Studies suggest that exercise is feasible and beneficial for lymphoma patients, with no major safety concerns reported.24678

How does the exercise program treatment for lymphoma differ from other treatments?

The exercise program for lymphoma is unique because it focuses on improving physical activity and fitness to enhance survival outcomes and reduce fatigue, rather than using medication or traditional therapies. This approach is novel as it aims to break the cycle of fatigue and inactivity, which is common in lymphoma patients, and improve overall quality of life.14689

What is the purpose of this trial?

This study aims to see if a 12-week exercise program designed to reduce long periods of inactivity is feasible in newly diagnosed lymphoma participants receiving R-CHOP or POLA-R-CHP chemotherapy treatments, and whether it can improve heart health and reduce chemotherapy drug side effects.

Research Team

CD

Christina Dieli-Conwright, MD, PhD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

This trial is for newly diagnosed lymphoma patients starting R-CHOP or POLA-R-CHP chemotherapy. It's designed to help those who lead a sedentary lifestyle. Specific eligibility criteria are not provided, but typically include being medically stable and able to participate in an exercise program.

Inclusion Criteria

Access to a phone that can receive text messages
Ability to understand and the willingness to sign informed consent prior to any study-related procedures
Engaging in ≤60-minutes of structured moderate or vigorous intensity exercise
See 4 more

Exclusion Criteria

Unstable comorbidities that prevent participation in moderate-to-vigorous intensity exercise
Participate in more than 60 minutes of structured moderate-to-vigorous exercise per week over the last month
Subjects who in the opinion of the investigators may not be able to comply with the safety monitoring requirements of the study
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Baseline Assessment

Assessments of fitness and physical health, blood tests, and questionnaires

1 week
1 visit (in-person)

Treatment

Participants receive standard of care chemotherapy and engage in a 12-week exercise program to reduce sedentary time

12 weeks
Daily exercise sessions in-clinic up to 4x weekly and at home 6 days per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week
Week 14 post-intervention visit

Treatment Details

Interventions

  • Interrupted Sedentary Time Intervention
Trial Overview The iSTAND Trial tests a 12-week exercise intervention aimed at reducing sedentary time during chemotherapy treatment for lymphoma. The goal is to see if this can improve heart health and lessen the side effects of chemotherapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Interrupted Sedentary Time InterventionExperimental Treatment1 Intervention
The first 3 participants enrolled with be placed into the intervention group. After this, participants will be randomized in a group allocation ratio of 2:1 using permuted blocked design with varying block size and stratified by treatment plan. 14 participants will complete: * Baseline visit * Standard of care chemotherapy treatment regimen * Daily exercise sessions in-clinic up to 4x weekly and at home 6 days per week * Week 14 post-intervention visit
Group II: Usual Care Control GroupActive Control1 Intervention
Participants will be randomized in a group allocation ratio of 2:1 using permuted blocked design with varying block size and stratified by treatment plan. 7 participants will complete: * Baseline visit * Standard of Care chemotherapy treatment regimen * Week 14 visit * Participants will be offered Fitbit activity tracker and resistance bands at the end of the study.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+

Findings from Research

A systematic review of 11 studies with 1530 cancer patients found that supervised physical activity significantly reduces cancer-related fatigue, with a strong effect size (SMD = -1.69).
Both combined aerobic and resistance training, as well as aerobic, resistance, and stretching exercises, were effective in reducing fatigue, suggesting these should be included in cancer rehabilitation programs.
Supervised exercise reduces cancer-related fatigue: a systematic review.Meneses-Echávez, JF., González-Jiménez, E., Ramírez-Vélez, R.[2022]
A feasibility study involving 14 young adults (ages 20-34) undergoing chemotherapy showed that they are willing to participate in physical activity research, indicating potential for future studies.
Participants reported significant variability in their physical activity levels and experienced high levels of fatigue, suggesting a need for interventions to enhance physical activity during cancer treatment to help manage symptoms.
A Feasibility Study to Measure Physical Activity, Fatigue, Sleep-Wake Disturbances, and Depression in Young Adults During Chemotherapy.Erickson, JM., Adelstein, KE., Letzkus, LC.[2021]
In a study of 60 lymphoma patients participating in a 12-week exercise program, adherence to the exercise regimen was high at 77.8%.
Younger patients (under 40), those with a history of insufficient physical activity, previous radiation treatment, higher body mass index, and smokers showed poorer adherence, highlighting key factors that could inform targeted interventions to improve exercise participation in lymphoma patients.
Predictors of adherence to supervised exercise in lymphoma patients participating in a randomized controlled trial.Courneya, KS., Stevinson, C., McNeely, ML., et al.[2018]

References

Evidence-based exercises intervention in adults diagnosed with Lymphoma. [2022]
Physical activity and quality of life in adult survivors of non-Hodgkin's lymphoma. [2021]
Supervised exercise reduces cancer-related fatigue: a systematic review. [2022]
The association of physical activity before and after lymphoma diagnosis with survival outcomes. [2023]
Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. [2022]
Predictors of follow-up exercise behavior 6 months after a randomized trial of supervised exercise training in lymphoma patients. [2015]
A Feasibility Study to Measure Physical Activity, Fatigue, Sleep-Wake Disturbances, and Depression in Young Adults During Chemotherapy. [2021]
Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. [2018]
Predictors of adherence to supervised exercise in lymphoma patients participating in a randomized controlled trial. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security